Chargement de la fiche…
Chargement de la fiche…
rhumatologie
Praticien hospitalier
Brest (29609)
Rheumatoid Arthritis Research and Therapies · Vasculitis and related conditions · Systemic Lupus Erythematosus Research
Tout est calculé à partir des sources publiques (RPPS, PubMed, OpenAlex, OpenStreetMap…) — aucun classement éditorial.
2021–2026
Inserm
2021–2026
Université de Bretagne Occidentale
2022
American Cancer Society
2022
Centers for Disease Control and Prevention
2022
United States Department of Health and Human Services
2022
National Institute on Drug Abuse
0
h-index
0
i10
0
citations
Le h-index mesure la productivité scientifique : ce médecin a publié 8 articles cités au moins 8fois par d'autres chercheurs. Plus c'est élevé, plus son travail influence la communauté médicale.
Côté patient
Comprendre votre pathologie, exercices à domicile, applications validées, paramédicaux à proximité — gratuit, sans inscription.
DES Rhumatologie · Rhumatologie (SM) — Diplôme d'Études Spécialisées
DE Docteur en médecine — Capacité / Certificat d'Études Spéciales
0
travaux
0
h-index
0
i10-index
0
citations
2026Annals of the rheumatic diseases
PubMed ↗Transcriptomic stratification predicts response to rituximab, abatacept, or the association of hydroxychloroquine and leflunomide in 3 randomised controlled clinical trials of Sjögren's disease
2025Joint bone spine
PubMed ↗Tapering or stopping tocilizumab in PMR: Toward optimized treatment withdrawal
2025Arthritis & rheumatology (Hoboken, N.J.)
PubMed ↗Maintenance of Remission After Tocilizumab Withdrawal in Patients With Glucocorticoid-Dependent Polymyalgia Rheumatica
2024Rheumatology (Oxford, England)
PubMed ↗Efficacy and management of tocilizumab in polymyalgia rheumatica: results of a multicentre retrospective observational study
2023The Journal of rheumatology
PubMed ↗Long-Term Opioid Therapy Among Patients With Systemic Lupus Erythematosus in the Community: A Lupus Midwest Network (LUMEN) Study
2023Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases
PubMed ↗Health Care Utilization in Systemic Lupus Erythematosus in the Community: The Lupus Midwest Network
2022The Journal of rheumatology
PubMed ↗COVID-19 Vaccine Uptake Among Patients With Systemic Lupus Erythematosus in the American Midwest: The Lupus Midwest Network (LUMEN)
2022Arthritis research & therapy
PubMed ↗Utilization of preventive services in a systemic lupus erythematosus population-based cohort: a Lupus Midwest Network (LUMEN) study
2025Drugs & aging
PubMed ↗Aging in Granulomatosis with Polyangiitis and Microscopic Polyangiitis: From Pathophysiology to Clinical Management
2024Joint bone spine
PubMed ↗Recommendations of the French Society of Rheumatology for the management in current practice of patients with polymyalgia rheumatica
2023RMD open
PubMed ↗Utilisation of cardiovascular preventive services in a rheumatoid arthritis population-based cohort
2023Clinical and experimental rheumatology
PubMed ↗Towards a universal definition of disease activity score thresholds: the AS135 score
2026Annals of the rheumatic diseases
PubMed ↗Transcriptomic stratification predicts response to rituximab, abatacept, or the association of hydroxychloroquine and leflunomide in 3 randomised controlled clinical trials of Sjögren's disease
2023Joint bone spine
PubMed ↗How rare is primary Sjögren's syndrome?
2025Joint bone spine
PubMed ↗Clinical presentation and treatment response in ACPA-negative rheumatoid arthritis
2026Annals of the rheumatic diseases
PubMed ↗Transcriptomic stratification predicts response to rituximab, abatacept, or the association of hydroxychloroquine and leflunomide in 3 randomised controlled clinical trials of Sjögren's disease
2023Arthritis & rheumatology (Hoboken, N.J.)
PubMed ↗Incidence, Prevalence, and Mortality of Lupus Nephritis: A Population-Based Study Over Four Decades Using the Lupus Midwest Network
2025Joint bone spine
PubMed ↗Tapering or stopping tocilizumab in PMR: Toward optimized treatment withdrawal
2024Autoimmunity reviews
PubMed ↗The pipeline of immunomodulatory therapies in polymyalgia rheumatica and giant cell arteritis: A systematic review of clinical trials
2024Autoimmunity reviews
PubMed ↗The pipeline of immunomodulatory therapies in polymyalgia rheumatica and giant cell arteritis: A systematic review of clinical trials
2025Article
Transcriptomic stratification predicts response to rituximab, abatacept, or the association of hydroxychloroquine and leflunomide in 3 randomised controlled clinical trials of Sjögren’s disease
Annals of the Rheumatic Diseases
2025Article
Maintenance of Remission After Tocilizumab Withdrawal in Patients With Glucocorticoid‐Dependent Polymyalgia Rheumatica
Arthritis & rheumatology
2025Article
Aging in Granulomatosis with Polyangiitis and Microscopic Polyangiitis: From Pathophysiology to Clinical Management
Drugs and Aging
2025Article
Biothérapies, rhumatismes inflammatoires chroniques (deuxième partie)
Revue du Rhumatisme
2024Article
Clinical Presentation and Treatment Response in ACPA-negative Rheumatoid Arthritis
Joint Bone Spine
2024Article
The pipeline of immunomodulatory therapies in polymyalgia rheumatica and giant cell arteritis: A systematic review of clinical trials
Autoimmunity Reviews
2024Article
Dual MPO/PR3 ANCA positivity and vasculitis: insights from a 7-cases study and an AI-powered literature review
Rheumatology
2024Article
Recommendations of the French Society of Rheumatology for the management in current practice of patients with polymyalgia rheumatica
Joint Bone Spine
Rhumatologues à proximité